Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com
Equities researchers at StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the stock. Bio-Path Stock Performance NASDAQ BPTH opened at $0.18 on Tuesday. The business’s fifty day simple moving average is $0.16 and its 200-day […]
More Stories
Federal Reserve Keeps Interest Rates Unchanged, Signals 2 Cuts This year
By Andrew Moran The Federal Reserve kept interest rates unchanged for the fourth straight meeting on June 18, a decision...
Trust Point Inc. Cuts Position in The Boeing Company (NYSE:BA)
Trust Point Inc. decreased its position in The Boeing Company (NYSE:BA – Free Report) by 15.4% during the first quarter,...
Prime Day Just Got Even Better With Amazon’s Exciting Free Game Offers
Ahead of the long-awaited Prime Day 2025, Amazon has already started offering a surprise to its Prime Members – free...
Exchange Traded Concepts LLC Reduces Position in Merck & Co., Inc. (NYSE:MRK)
Exchange Traded Concepts LLC decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 74.8%...
Capital One Shopping Review: Save More While You Shop Online
In this digital shopping era, getting your hands on the best deals can be a little time-consuming, but not for...
Top Electric Vehicle Stocks To Follow Today – June 15th
Tesla, Shell, Rivian Automotive, Navitas Semiconductor, and Enphase Energy are the five Electric Vehicle stocks to watch today, according to...